ABCLAbCellera Biologics Inc. Common Shares

CSNasdaq (XNAS)·USD

Identity

Security key: 11179
Ticker: ABCL
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2020-12-11
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: ABCL

Detail

Enriched 2026-08-14 20:47

Market cap: $3,174,961,730.43
Shares outstanding (class): 306,611,466
Shares outstanding (weighted): 306,611,466
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 562
Location: VANCOUVER, A1
Homepage: https://www.abcellera.com
Description: AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Market cap and share counts drift.

Funds holding this security

8 funds · 8 positions · $56.82M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
SMALLCAP World Fund Inc SMALLCAP World Fund Inc	—	$46.63M	0.06%	13,361,096 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$6.04M	0.07%	1,732,022 NS	FIGI
State Street(R) SPDR(R) Portfolio Developed Wor… SPDR INDEX SHARES FUNDS	SPDW	$1.97M	0.01%	564,888 NS	FIGI
Driehaus Micro Cap Growth Fund Driehaus Mutual Funds	—	$869.8K	0.19%	249,240 NS	FIGI
State Street(R) SPDR(R) S&P(R) International Sm… SPDR INDEX SHARES FUNDS	GWX	$573.5K	0.07%	164,325 NS	FIGI
Small Cap Value Fund Northern Funds	—	$431.8K	0.07%	123,712 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$232.4K	0.01%	66,600 NS	FIGI
Diversified Equity Master Portfolio Master Investment Portfolio	—	$61.7K	0.00%	17,689 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERABCL
FIGI_COMPOSITEBBG00LLW2MF2
FIGI_SHARE_CLASSBBG00LLW2MH0
CIK0001703057
ISINCA00288U1066
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: AbCellera is a biotechnology company focused on antibody discovery and development.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.